FORT MYERS, Fla. (PRWEB) September 04, 2013
21st Century Oncology has partnered with Yale School of Medicine’s Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center and the Department of Therapeutic Radiology to bolster comparative effectiveness research in the radiation oncology community and to address the critical challenges clinicians, policy makers and cancer patients and their families face today.
Yale’s interdisciplinary COPPER Center, in close collaboration with the Yale Department of Therapeutic Radiology, has a rich history of conducting cancer effectiveness and outcomes research, aiming to improve cancer care and reduce the burden of cancer for individual patients and society. 21st Century Oncology is the largest provider of radiation oncology services in the United States. With their expansive network of radiation therapy treatment centers both domestic and abroad and their dedication to advanced, integrated cancer care, 21st Century Oncology has the unique ability to touch the lives of patients and their families through continuous innovation and improvement.
President, CEO and Co-Founder of 21st Century Oncology, Daniel Dosoretz, M.D., F.A.C.R., F.A.C.R.O. believes the partnership has great potential. “Our focus on our patients is our number one goal,” says Dr. Dosoretz. “This collaboration with Yale School of Medicine will allow us to continue to support rigorous, patient-centered research and be an agent for improvement and an advocate for every person who walks through our doors.”
“We could not be more excited about this new initiative,” said Cary Gross, M.D., Director of the COPPER Center. “We believe that the breadth of clinical experience, diverse practice environments and patient populations and rich data from the 21st Century O
Copyright©2012 Vocus, Inc.
All rights reserved